Linn Energy Is a Buy
Health Care: Drugs
Aegerion Pharmaceuticals Inc. (AEGR: NASDAQ)
$58.25 -1.77 | -2.95%
05/22/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 60.02 |
| 52 Week High | 63.72 |
| 52 Week Low | 12.87 |
| Avg. Daily Vol. (Mil) | 0.64 |
| Beta (3 year) | 0.68 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,729.72 |
| Shares Out (Mil) | 28.82 |
| Float (Mil) | 21.22 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 11.00 |
| Current Ratio | 11.70 |
| LT Debt/ Equity | 0.05 |
| Total Debt / Equity | 0.08 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.41K |
| Price/Book | 13.65 |
| Price/Cash Flow | -18.60 |
| Per Share Data | |
| Earnings | -2.74 |
| Sales | 0.04 |
| Book Value | 4.40 |
| Cash Flow | -3.23 |
| Business Summary | |
|---|---|
| General Information | |
| CenterPointe IV
1140 Route 22 East Bridgewater, NJ 08807 |
|
| www.aegerion.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 113 | |
| CEO: Mr. Marc D. Beer | |
| Short Interest | |
| Current Month (Mil) | 3.22 |
| Previous Month (Mil) | 3.19 |
| Short Interest Ratio (Days) | 5.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -64.60 |
| Return on Investments | -70.00 |
| Profitability | |
| Gross Margin | 85.10 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with AEGR
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Rising On Unusual Vo...
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Rising On Unusal Vol...
- ContributorStocks With Big Insider Buy...
Latest AEGR Headlines from TheStreet
- Aegerion Pharmaceuticals To Announce First Quarter 2013 Financial Results On Tuesday, April 30 04.16.13 | 08:04 am
- Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program 04.03.13 | 04:04 pm
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- 10 Stocks Insiders And Hedge Funds Think Will Go Higher 03.11.13 | 01:03 pm
- Aegerion Pharmaceuticals Announces Fourth-Quarter And Year-End 2012 Financial Results 03.06.13 | 07:03 am
- Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program 03.05.13 | 04:03 pm
- 5 Stocks Set to Soar on Bullish Earnings 03.04.13 | 01:03 pm
- Aegerion Pharmaceuticals Observes Rare Disease Day 02.28.13 | 08:02 am
- Aegerion Pharmaceuticals Announces Presentation At The Cowen And Company 33rd Annual Health Care Conference 02.27.13 | 08:02 am
- Aegerion Pharmaceuticals To Announce Fourth Quarter 2012 Financial Results On Wednesday, March 6 02.20.13 | 08:02 am
Press Releases for AEGR
- Insmed Appoints Will Lewis As President And Chief Executive Officer - PR Newswire 09.11.12 | 08:09 am
- Aegerion Pharmaceuticals Chief Executive Officer Marc D. Beer (Video: Business Wire) - Business Wire 09.29.11 | 08:09 am
Partner Headlines for AEGR
- Insider Buying Trends: Are These Cash Rich Companies Ready To Rally? - Seeking Alpha 03.15.13 | 09:03 am
- UPDATE: Canaccord Genuity Raises PT to $44 on Aegerion Pharmaceuticals on Encouraging Sales Data - Benzinga 03.07.13 | 01:03 pm
- UPDATE: Deutsche Bank Raises PT on Aegerion Pharmaceuticals on Strong Juxtapid Uptake - Benzinga 03.06.13 | 01:03 pm
- Pre-Market Earnings Report for March 6, 2013 : SPLS, BF/B, AEO, TFM, BIG, AEGR, HOV, WD, TRK, QRE, WILN, MFB - NASDAQ 03.05.13 | 09:03 pm
- Calendar Spreads On Intuitive Surgical, Riverbed Technology And Sandisk - Seeking Alpha 10.19.12 | 09:10 am
- Benzinga Mid-Day Market Update - Benzinga 10.17.12 | 12:10 pm
- 5 Pharmaceutical Companies With EMA Catalysts During The Next 3 - 12 Months - Part II - Seeking Alpha 09.02.12 | 08:09 am
- Aegerion Pharmaceuticals Announces Date of FDA Advisory Committee Review of Lomitapide NDA - Benzinga 08.14.12 | 09:08 am
- 16 Healthcare Stocks Deeply Discounted From Target Price - Seeking Alpha 01.12.12 | 09:01 am
- UPDATE: Aegerion Pharmaceuticals Files Registration Statement for Proposed Offering of 4.25M Shares - Benzinga 06.16.11 | 04:06 pm
